CN1839702A - Compound Gynostemma pentaphylla tea for assisting invigorating brain and heart and its preparation method - Google Patents
Compound Gynostemma pentaphylla tea for assisting invigorating brain and heart and its preparation method Download PDFInfo
- Publication number
- CN1839702A CN1839702A CNA2005100654247A CN200510065424A CN1839702A CN 1839702 A CN1839702 A CN 1839702A CN A2005100654247 A CNA2005100654247 A CN A2005100654247A CN 200510065424 A CN200510065424 A CN 200510065424A CN 1839702 A CN1839702 A CN 1839702A
- Authority
- CN
- China
- Prior art keywords
- tea
- cerebrovascular diseases
- orders
- medicinal
- gynostemma pentaphylla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a health tea for delaying senility and treating cardiovascular and cerebrovascular diseases, which is prepared from gynostemma pentaphylla, ginkgo leaves, fleece-flower root, haw, cassia seed and wolfberry fruit through the steps of drying, quick-frying, freeze-drying or comminuting, formulating proportionally, thermalizing, sterilizing to obtain powder, bagged agent or block agent.
Description
The present invention relates to a kind of health protection tea of can delay senility prevention and supplemental treatment cardiovascular and cerebrovascular disease, is the health protection tea of feedstock production with the Chinese herbal medicine specifically, the invention still further relates to the preparation method of this tea.
Cardiovascular and cerebrovascular disease is still the higher common frdquently encountered disease of the incidence of disease at present, and bigger to the elderly's harm, the clinical treatment difficulty is big, and the trend that increases is year by year arranged, and the disability rate of dying of illness is higher, multiple a kind of acute and chronic cardiovascular and cerebrovascular disease of healing than refractory again.
Cardiovascular and cerebrovascular diseases are frequently-occurring diseases, heal than refractory again, and the patient is endangered seriously.Owing to be a kind of with human circulation artery syndrome,, smoking higher with partial eclipse, salt, animal tallow intake, drink, eating and drinking without temperance, obesity etc. be relevant, cause the rising of hypertension, high fat of blood, hyperglycaemia and teinemia and blood viscosity, atherosclerotic causes the lumen of vessels stenosis or occlusion and the heart and brain pathology that causes.Wherein dying from cardiovascular and cerebrovascular disease is the first place of common disease, and hypertensive encephalophathy, hypertensive cardiopathy and crown AHD are the common causes of death of person in middle and old age's sufferer.
All many to medicine, the health protection tea kind of cardiovascular and cerebrovascular diseases both at home and abroad at present, and effect is lower, not fairly obvious, the patient still has to depend on some Western medicine, but side effect is big, and for a long time with easily producing anti-medicine body, the Chinese patent drug effect is slow, and curative effect is lower.
The object of the present invention is to provide a kind of have delay senility, again can be hypotensive, reducing blood lipid, hypoglycemic, antifatigue, anti-anoxic makes eye bright, thrombolysis, improve high blood coagulation state, the mediation microcirculation strengthens immunity of organisms, the generation morbidity and the health body-building medicinal tea of prevention, minimizing, alleviation cardiovascular and cerebrovascular diseases.
Another object of the present invention provides the preparation method of this cardiovascular and cerebrovascular diseases health protection tea.
Solution of the present invention is based on motherland's medical science to cardiovascular and cerebrovascular and pathogenetic understanding of other complication and dietotherapy principle, achieve with reference to the Chinese medicine modern pharmacological research, from motherland's medicine treasure-house, filter out have enriching yin, tonifying Qi, promoting blood circulation and removing blood stasis, lipopenicillinase, hypotensive, make eye bright, thrombolysis, strengthen the body resistance to consolidate the constitution the natural green food plant medicine of the kind homology of medicine.Seminar side skims the cream off milk according to the modern Chinese medicine pharmacology, make its performance reduction vascular resistence that stimulates circulation, increase biologically active, promote the reduction of blood fat, reducing blood fat and fat protein decomposes, cholesterol, blood fat, blood sugar are reduced, improve blood circulation, can prevent to reduce the effect that development takes place the pathology of alleviating cardiovascular disease, cerebrovascular disease.
Medicine of the present invention is made (consumption is a weight portion) by following component
Gynostemma pentaphylla 20-30 part ginkgo leaf 10-20 part fleece-flower root 10-20 part
Hawthorn 5-15 part cassia seed 5-15 part fruit of Chinese wolfberry 10-25 part
The prescription preferred weight ratio range of preparation medicine of the present invention is:
Gynostemma pentaphylla 10-20 part ginkgo leaf 8-15 part tuber of multiflower knotweed 5-10 part
Hawthorn 5-10 part cassia seed 5-10 part fruit of Chinese wolfberry 10-15 part
The optimum weight proportioning of medicine of the present invention is:
5 parts of 5 parts of fleece-flowers root of 10 parts of ginkgo leaves of Gynostemma pentaphylla
4.5 parts of 5 portions of fruits of Chinese wolfberry of 5 parts of cassia seeds of hawthorn
Above-mentioned each component is made medicine production method of the present invention is:
1, gets clean glue thigh orchid earlier,, be crushed to slightly end of 60 orders 40-50 ℃ of oven dry;
2, with ginkgo leaf water clean after, 40 ℃ of oven dry, be crushed to slightly end of 60 orders;
3, get the fleece-flower root, haw flakes,, be crushed to slightly end of 60 orders 50-60 ℃ of oven dry;
4, depend on pine torch water clean air-dry after, fry to cause with slow fire and littlely take out when cracker being arranged and fragrance being arranged, cool and be ground into slightly end of 60 orders;
5, with the fruit of Chinese wolfberry after 10-15 ℃ of freeze drying, be ground into 60 orders slightly the end;
6, above-mentioned whole thick last agent component is mixed in described ratio after, under 90-100 ℃, carry out thermalization, sterilization treatment 5-10 minute, can obtain the thick powder tea product of health care of drinking of cardiovascular and cerebrovascular diseases.
The thermalization disinfecting action here is to adopt step type cooling thermalization sterilization, and temperature is raised to 100 ℃ rapidly, and segmentation thereafter drops to 90 ℃, 5-10 minute.
Powder after the sterilization can be processed into block type, by the steaming of boiling, makes type under negative pressure, does not add any interpolation stick, and dry back also can be made into bag bag medicinal tea with vacuum packaging.
Important feature of the present invention is to contain abundant nutrition in the medicinal tea, contains more than 80 kind of saponin in the plant medicinal tea, 79 kinds of called after gypenosides wherein 4 kinds consistent with the panaxoside structure respectively, be the tetracyclic triterpene dammarane type.Also contain a certain amount of vitamin C and malonic acid, rutin, phytolaccanine, carbohydrate, leaf stripe, flavones, sterol, phosphatide, sweet theophylline, thiamine, nicotinic acid, ascorbic acid, the cyanogen glucoside, gibberellin, ribonucleic acid, enzyme, protein, fat, carbohydrate, carrotene, riboflavin, tannin, aloe-emodin, obtusin, tuber of multiflower knotweed acetyl, the benzene glucoside, crude fat, starch and asparatate, threonine, 18 seed amino acids such as serine, overall your energy of amino acid that is needed by human can strengthen immunity of organisms, particularly arginine wherein, lysine, the strongest with leucic effect.
Also contain 23 kinds of inorganic elements such as iron, zinc, potassium, magnesium, copper, manganese, calcium, chromium, phosphorus, sodium, selenium in addition in cardiovascular and cerebrovascular medicinal tea of the present invention, these elements are the prothetic groups that constitute the plurality of enzymes of body.(SOD) plays the catalytic activity effect to Superoxide Dismutase in the cardiovascular and cerebrovascular.
Another important feature of the present invention is to contain abundant water-soluble cellulose and anthraquinone compounds in the medicinal tea, can promote gastrointestinal emptying, reduces sugared, fatty absorption, helps reducing blood cholesterol and triglyceride.Also contain abundant chromocor compound in this medicinal tea and can reduce blood fat in the blood, blood viscosity, promote blood speed to follow and microcirculation, strengthen cardiovascular and cerebrovascular and blood flow speed and follow perfusion, help reducing developing of prevention cardiovascular and cerebrovascular diseases.
The clinical use result of medicine medicinal tea of the present invention shows that following advantage is arranged:
1, to select herbal cuisine for use be raw material with the green natural food plant medicine in source in the present invention, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment cardiovascular and cerebrovascular diseases of the Chinese medicine of respectively distinguishing the flavor of, and do not have chemical sweetener, nontoxic to human body.
2, the present invention need not decoct, and mouthfeel is moderate, and is nutritious, can for tea-drinking it, taking convenience meets state food health legislation regulation.
3, light disease person can use separately, state of an illness weight person, can with the medication combined use of other treatment cardiovascular and cerebrovascular diseases, but can significantly reduce the dose of common lipopenicillinase and cardiovascular and cerebrovascular diseases medicine, result of treatment increases significantly, and can significantly reduce blood fat, blood pressure and eliminate other complication, strengthen the immunity of body.
4, the present invention can replace medicines of some treatment cardiovascular and cerebrovascular diseases and expensive blood fat-reducing blood pressure-decreasing medicine thereof, drinks product of the present invention after 3 courses of treatment, can replace the part cardiovascular and cerebrovascular medicine.
Health protection tea of the present invention is the clinical effectiveness that shows cardiovascular and cerebrovascular diseases, and the present invention observes through 168 routine systems, and selection medical history, the state of an illness, age, sex and suitable cardiovascular and cerebrovascular patient 80 examples of former methods of treatment are control group.First group curative effect obviously is better than the second group as a result.
Diagnostic criteria: the whole cases of the present invention are all by in " new Chinese medicine clinical research guideline ", and " new Chinese medicine treatment hyperlipidemia and apoplexy " " interior rattan Zhou Hua,, Japan in 1980 " makes the traditional Chinese and western medicine dual diagnosis.Lipid determination T-CHOL＞5.27mmd/L (220mg/dl), or triglyceride＞1.32mmol/L (120mg/dl) (T-CHOL mensuration Abell method, triglyceride mensuration V
2NH
2The ndel method).The patient all meets the Western medicine diagnose standard, and sweep seedling through head CT and make a definite diagnosis and suffered from cerebral thrombosis and cerebral embolism, meet the tcm diagnosis standard simultaneously, be diagnosed as apoplex involving the channels and collaterals type apoplexy, the obstruction of qi in the chest, phlegm syndrome, quench one's thirst etc., allly meet above-mentioned condition, adhering to 3 of the long-term drinking above person course of treatment, is the selected scope of case.
The case choice criteria: the present invention is according to cholesterol, triglyceride disease, hypertensive cerebral apoplexy, the coronary heart disease diagnosis standard of hyperlipidemia, through clinic case and selected medical history, the state of an illness, sex, age and methods of treatment, be divided into first group and second group in 2: 1 ratios at random in the prescription on individual diagnosis order, drinking medicinal tea of the present invention is the first group, and drinking YINCHEN JIANGZHI CHA is the second group.First group 168 examples, male 104 examples, women 64 examples, age 39-76 year, the course of disease 2 months-20 years, Western medicine diagnose was suffered from cerebral thrombosis 122 examples, suffered from coronary heart disease and cerebral embolism 46 examples.Tcm syndrome differentiation and typing: 1. extreme hyperactivity of the liver-yang, wind-fire upper harassing syndrome 45 examples; 2. wind phlegm hemostasis, numbness group train of thought is demonstrate,proved 50 examples; 3. the hot internal organs of phlegm is real, syndrome of wind-phlegm invading upward 36 examples; 4. qi deficiency to blood stasis disease 19 examples; 5. 18 examples are demonstrate,proved in wind formation from yin deficiency.In 168 examples with high blood pressure 103 examples, coronary heart disease 54 examples, hyperlipidemia 81 examples, hypercoagulable blood 118 examples, diabetes 25 examples.Second group 80 examples, male 50 examples, women 30 examples, age 40-70 year, the course of disease 1 month-18 years.Western medicine diagnose formed 58 examples for suffering from coronary disease and cerebral thrombosis, suffered from cerebral embolism 22 examples.Tcm syndrome differentiation and typing: 1. extreme hyperactivity of the liver-yang, wind-fire upper harassing syndrome 21 examples; 2. wind phlegm hemostasis, numbness group train of thought is demonstrate,proved 26 examples; 3. the hot internal organs of phlegm is real, syndrome of wind-phlegm invading upward 14 examples; 4. qi deficiency to blood stasis disease 10 examples; 5. 9 examples are demonstrate,proved in wind formation from yin deficiency.In 80 examples with high blood pressure 52 examples, coronary heart disease 27 examples, hyperlipidemia 31 examples, hypercoagulable blood 55 examples, diabetes 5 examples.Two groups of patient's sexes, age, the course of disease, tcm syndrome differentiation and typing, complication and every laboratory indexes difference before treatment do not have conspicuousness, have comparativity (P＞0.05).
Grouping medication: under identical condition, drink for two groups, after the medication of leaving hospital, reach outpatient service selection case, the hyperlipidemia of making a definite diagnosis, high blood pressure, coronary heart disease, high blood viscosity disease, diabetes are observed on the basis of dietetic treatment and drug therapy, and the first group is drunk the auxilliary tea for the treatment of of the present invention.Hyperlipidemia and vascular hypertension 20-30 every day gram, boiling water brews, and early, middle and late empty stomach is drunk better, coronary heart disease and hypercoagulable blood gram every days 30, boiling water brews, and drinks better sooner or later on an empty stomach, and restrain diabetes every days 20, and boiling water brews, and early, middle and lately drinks after meal.3 months is a course of treatment, drinks 3 courses of treatment, and other lipopenicillinase or antidiabetic drug can reduce or withdraw gradually, adds up effect 3 courses of treatment.The second group: lipid lowerers treatment routinely, fat-reducing medicament wherein, kind consumption usage and first group are complementary, and adopt commercially available YINCHEN JIANGZHI CHA and tuber of multiflower knotweed fat decreasing tea, choose any one kind of them.Every day, 10-20 restrained, and boiling water brews for tea-drinking, and 3 months is a course of treatment, adds up effect 3 courses of treatment.
First and second groups all can cooperate therapies such as pedicure, acupuncture, and to two groups of complication, hypertension, coronary heart disease, high fat of blood diabetes etc. are selected suitable medicine symptomatic treatment respectively for use.Observe cholesterol, triglyceride, hyperlipemia disease master disease, comprise uncomfortable in chest or the headache body heavy, the tinnitus dim eyesight, the fat body of shape is real, constipation etc.
Experimental technique: get compound Gynostemma pentaphylla tea for assisting invigorating brain and heart of the present invention, make with the ventilative cotton paper of refined plant fiber and build the square pouch, every bag 10 gram dress.Be put into during drink-service in the cup, with boiling water 200-300ml more than 90 ℃ soak 10-15 minute promptly drinkable, can wash water 2-3 time open for every bag.As symptom person obviously, every day drinkable 2-3 bag, the not obvious person of symptom, drinkable 1-2 bag is drunk according to the amount of drinking water of oneself is the amount doesn't matter.The second group is drunk YINCHEN JIANGZHI CHA with identical method.The results of regular determination index, serum cholesterol, triglyceride, high-density protein, low-density albumen.Whole blood contrast viscosity, packed cell volume, fibrinogen, two groups of patients all adopt full diet, and the morning is blood-sample withdrawal on an empty stomach, the above every inspection of same sample censorship.
Curative effect judging standard: the first group is drunk the auxilliary tea for the treatment of of compound Gynostemma pentaphylla of the present invention, and the second group is drunk YINCHEN JIANGZHI CHA.Two groups are detected index with quadrat method.Recovery from illness serum cholesterol and triglyceride are reduced to normal level.Obviously descend before improvement serum cholesterol and triglyceride are drunk, but do not reduce to normal level.Drink 3 courses of treatment, primary symptom disappears, and test rating meets the alleviation condition fully, drinks continuously can keep alleviating, and detects index and is tending towards the normal recovery from illness that is.Drink 3 courses of treatment, cardinal symptom takes a turn for the better, and most of transference cure, test rating meet the alleviation condition substantially, drinks continuously and detects index decline near normal, is produce effects.Drink 3 courses of treatment, cardinal symptom takes a turn for the better to some extent, and most of symptom has improvement, detects index and descends to some extent, for effectively.After drinking 3 courses of treatment, primary symptom makes moderate progress, and detecting index has decline and instability slightly, for invalid.
The statistics of experimental data and analysis: drink the back clinical symptoms for first and second groups and improve relatively: table 1 shows, drinks the back to hyperlipidemia, high blood pressure, high blood viscosity disease, coronary heart disease, the normal main clinic symptoms that occurs of diabetes for two groups; Dizziness headache, body weigh weak, slow slow-witted abdominal distension, chest distress or latent painful, impetuous, nervous insomnia, bitter taste, and tinnitus dim eyesight, the doing well,improving of having aches in the limbs all have effect preferably.The second group is to the best results of dizziness headache, and total effective rate 94.4% is to malaise, the improvement of indigestion and loss of appetite abdominal distension, chest distress or latent symptom such as painful is relatively poor, total effective rate 78.3%, the first group all has very good effect to the improvement of each clinical symptoms, total effective rate 87.7%-95.5%.
The clinical symptoms that table 1 is taken behind the auxilliary treatment of the present invention tea, the YINCHEN JIANGZHI CHA is improved relatively:
| The example number | Routine number (%) is almost recovered | Produce effects example number (%) | Effective routine number (%) | Invalid routine number (%) | |
| Hyperlipidemia first group second group | 146 69 | 71(48.6) 18(26.1) | 41(28.1) 23(33.3) | 29(18.5) 22(31.9) | 7(4.8) 6(8.7) |
| High blood pressure first group second group | 138 66 | 51(37.0) 13(19.7) | 59(42.7) 16(24.2) | 11(8.0) 26(39.4) | 17(12.3) 11(16.7) |
| The sick first group of high blood viscosity second group | 124 58 | 41(33.1) 12(20.7) | 52(41.9) 16(27.6) | 22(17.7) 19(32.8) | 9(7.3) 11(18.9) |
| Coronary heart disease first group second group | 112 53 | 57(50.9) 15(28.3) | 27(24.1) 18(34.0) | 23(20.5) 17(32.1) | 5(4.5) 3(5.6) |
| Diabetes first group second group | 97 46 | 26(26.8) 12(26.1) | 42(43.3) 11(23.9) | 21(21.6) 13(28.3) | 8(8.3) 10(21.7) |
Drinking the front and back Hemorheology for first and second groups changes relatively: table 2 shows that the first group is drunk the whole blood contrast viscosity behind the present invention, and is before packed cell volume, fibrinogen are starkly lower than and drink (P＜0.05 or P＜0.01), especially remarkable to fibrinogenic improvement.Before the second group is drunk and had only packed cell volume to be lower than behind the old fat decreasing tea of bacterium to drink (P＜0.05), difference did not have conspicuousness before and after other laboratory indexes were drunk.Compare before and after drinking, hemorheological 3 index differences all have conspicuousness (P＜0.05 or P＜0.01).Illustrate that the blue heart and strengthening brain of living of compound glue thigh of the present invention is assisted treatment tea and the old fat decreasing tea of bacterium all can make hyperlipidemia cause that the hemorheology index of various cardiovascular and cerebrovascular diseases improves, and the blue curative effect of living the auxilliary treatment of heart and strengthening brain tea of compound glue thigh of the present invention is better than the old fat decreasing tea of bacterium.
Table 2 is taken the auxilliary tea front and back Hemorheology for the treatment of of the present invention and is changed relatively
| Grouping | The example number | Whole blood contrast viscosity (mpa.s) | Packed cell volume (%) | Fibrinogen (mg%) |
| Before and after the first group | 168 168 | 4.63±0.15 4.15±13 | 46.21±1.63 32.42±2.01 **Δ | 561.76±35.21 406.0±28.02 **Δ |
| Before and after the second group | 80 80 | 4.52±0.47 4.70±0.51 *Δ | 47.31±1.87 46.50±2.50 * | 531.19±47.42 520.23±32.43 |
First and second groups drink before and after Blood Lipid relatively: table 3 shows, it is remarkable that the first group is drunk the decline of cholesterol behind the present invention, triglyceride, low-density lipoprotein, HDL raise very remarkable (P＜0.05 or P＜0.01).Though the second group has downward trend after drinking YINCHEN JIANGZHI CHA, except that cholesterol, other index not statistically significants (P＜0.05).Compare between two groups, except that cholesterol, other indexs are improved the first group and are better than the second group, have significant difference (P＜0.05 or P＜0.01).Illustrate that drinking the present invention regulates lipometabolic effect aspect to hyperlipidemia and obviously be better than YINCHEN JIANGZHI CHA.
Table 3 is taken the auxilliary tea front and back Blood Lipid for the treatment of of the present invention and is compared
| Grouping | The example number | Cholesterol | Triglyceride | HDL | Low-density lipoprotein |
| Before and after the first group | 168 168 | 5.72±0.42 4.62±0.67 | 2.48±0.42 1.62±0.53 | 0.83±0.26 1.03±0.19 | 3.78±0.74 2.57±0.67 |
| Before and after the second group | 80 80 | 5.68±0.52 4.07±0.81 | 2.35±1.27 2.29±1.48 | 0.87±0.36 0.86±0.37 | 3.75±0.68 3.67±0.82 |
Test statistics shows: drink compound Gynostemma pentaphylla tea for assisting invigorating brain and heart of the present invention the comprehensive disease of 168 routine hyperlipemia is drunk test, obtain remarkable result 42 examples that are almost recovered, produce effects 85 examples, effective 32 examples, invalid 9 examples, cure-remarkable-effectiveness rate 75.6%, total effective rate are 94.64%.
Embodiment
Take by weighing raw material by following proportioning
1.5 kilograms of 2 kilograms of fleece-flowers root of 4 kilograms of ginkgo leaves of Gynostemma pentaphylla
1.5 kilograms of 1 kilogram of fruits of Chinese wolfberry of 1 kilogram of cassia seed of hawthorn
Production method is as follows:
Elder generation 40-50 ℃ of oven dry, is crushed to slightly end of 60 orders with Gynostemma pentaphylla; Again with ginkgo leaf water clean after, 40 ℃ of oven dry, be crushed to slightly end of 60 orders; Get the fleece-flower root, haw flakes and be crushed to slightly end of 60 orders 50-60 ℃ of oven dry; After other depends on that pine torch water is air-dry only, take out when the explosion product being arranged and fragrance is arranged, cool and be ground into slightly end of 60 orders with the slow fire stir-fry is extremely little; Again with the fruit of Chinese wolfberry after 10-15 ℃ of following freeze drying, be ground into 60 orders slightly the end; After above-mentioned several thick last components are pressed formula rate and mix, 100 ℃ of insulations 5-10 minute down, and then cool to 90 ℃ of insulations 10 minutes, such thermalization sterilization can have the mouth fragrance of green tea, makes medicinal tea.
Claims (6)
1, a kind of medicinal herb tea of can delay senility prevention and supplemental treatment cardiovascular and cerebrovascular diseases is characterized in that it is the medicinal tea of being made by the following weight proportion raw material
Gynostemma pentaphylla 10-20 part ginkgo leaf 8-15 part fleece-flower root 5-10 part
Hawthorn 5-10 part cassia seed 5-10 part fruit of Chinese wolfberry 10-15 part.
2, the medicinal herb tea of treatment cardiovascular and cerebrovascular diseases according to claim 1, wherein the weight proportion of each raw material is
5 parts of 5 parts of fleece-flowers root of 10 portions of ginkgoes of Gynostemma pentaphylla
4.5 parts of 5 portions of fruits of Chinese wolfberry of 5 parts of cassia seeds of hawthorn.
3,, it is characterized in that said medicinal tea is a said formulation on any medicinal tea book according to the medicinal herb tea of the described treatment cardiovascular and cerebrovascular diseases of claim 1.2.
4, the medicinal tea of treatment cardiovascular and cerebrovascular diseases according to claim 3 is characterized in that said medicinal tea is a powder, bag agent or piece agent.
5, the preparation method of the medicinal tea of the described treatment cardiovascular and cerebrovascular diseases of claim 4 is characterized in that getting earlier Gynostemma pentaphylla 40-50 ℃ of oven dry, is crushed to slightly end of 60 orders; With ginkgo leaf water clean after, 40 ℃ of oven dry, be crushed to slightly end of 60 orders; Get the fleece-flower root, hawthorn 50--60 ℃ of oven dry, be crushed to slightly end of 60 orders; After depending on that pine torch water dries only, taking-up cools and is ground into slightly end of 60 orders when cracker being arranged and fragrance is arranged with the slow fire stir-fry is extremely little; Get the fruit of Chinese wolfberry after 10--15 ℃ of following freeze drying, be ground into slightly end of 60 orders, after above-mentioned whole thick last agent component is mixed in described ratio, under 90--100 ℃, carry out thermalization, sterilization treatment 5-10 minute, make powder, bag agent or piece agent.
6, the preparation method that can prevent auxilliary treatment cardiovascular and cerebrovascular diseases powder according to claim 5, thermalization disinfecting action wherein is to adopt step type cooling thermalization to sterilize, and temperature is raised to 100 ℃ of segmentations thereafter rapidly drops to 90 ℃ of insulations 10 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005100654247A CN1839702A (en) | 2005-04-03 | 2005-04-03 | Compound Gynostemma pentaphylla tea for assisting invigorating brain and heart and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005100654247A CN1839702A (en) | 2005-04-03 | 2005-04-03 | Compound Gynostemma pentaphylla tea for assisting invigorating brain and heart and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1839702A true CN1839702A (en) | 2006-10-04 |
Family
ID=37029043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2005100654247A Pending CN1839702A (en) | 2005-04-03 | 2005-04-03 | Compound Gynostemma pentaphylla tea for assisting invigorating brain and heart and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1839702A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103005448A (en) * | 2013-01-08 | 2013-04-03 | 湖南麓山天然植物制药有限公司 | Health-care food composition for improving anoxia endurance and preparation method thereof |
| CN103156012A (en) * | 2013-03-04 | 2013-06-19 | 刘森 | Health protection tea |
| CN104721414A (en) * | 2014-04-21 | 2015-06-24 | 福建省龙岩市天马茗茶有限公司 | Gynostemma pentaphylla lipid-lowering tea |
| CN104855647A (en) * | 2015-05-18 | 2015-08-26 | 彭婷婷 | Health-care ginseng tea capable of resisting high blood pressure, high blood lipid and high blood sugar |
| CN107495367A (en) * | 2017-08-24 | 2017-12-22 | 四川省中医药科学院 | A kind of food, health products or pharmaceutical composition for improving hypoxia-bearing capability and its production and use |
| CN115025167A (en) * | 2022-07-25 | 2022-09-09 | 孙邈 | Gynostemma pentaphylla viscosity reducing liquid prescription and preparation process thereof |
-
2005
- 2005-04-03 CN CNA2005100654247A patent/CN1839702A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103005448A (en) * | 2013-01-08 | 2013-04-03 | 湖南麓山天然植物制药有限公司 | Health-care food composition for improving anoxia endurance and preparation method thereof |
| CN103156012A (en) * | 2013-03-04 | 2013-06-19 | 刘森 | Health protection tea |
| CN104721414A (en) * | 2014-04-21 | 2015-06-24 | 福建省龙岩市天马茗茶有限公司 | Gynostemma pentaphylla lipid-lowering tea |
| CN104855647A (en) * | 2015-05-18 | 2015-08-26 | 彭婷婷 | Health-care ginseng tea capable of resisting high blood pressure, high blood lipid and high blood sugar |
| CN107495367A (en) * | 2017-08-24 | 2017-12-22 | 四川省中医药科学院 | A kind of food, health products or pharmaceutical composition for improving hypoxia-bearing capability and its production and use |
| CN115025167A (en) * | 2022-07-25 | 2022-09-09 | 孙邈 | Gynostemma pentaphylla viscosity reducing liquid prescription and preparation process thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102919836B (en) | Health-care product capable of reducing blood glucose, releasing pressure, reducing lipid, relaxing bowel, beautifying, losing weight and resisting fatigue and production process thereof | |
| CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| KR101144059B1 (en) | Composition for prevention or treatment of diabete or obesity comprising Punica granatum extract and red ginseng extract | |
| WO2012034498A1 (en) | Product of functional health food that enhances organ immunity | |
| CN110447902B (en) | Composition with weight-losing effect | |
| CN102048224B (en) | Red jujube health-care beverage capable of removing chloasma, beautifying features and improving skin, and production technology thereof | |
| CN104642654A (en) | Health tea for controlling body weight, reducing uric acid and reducing hypertension, hyperglycemia and hyperlipemia | |
| CN107156363A (en) | A kind of complex tea with effect of weight reducing and preparation method thereof | |
| CN102258679B (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
| CN108524673A (en) | A kind of Chinese medicine composition and its application | |
| CN1839702A (en) | Compound Gynostemma pentaphylla tea for assisting invigorating brain and heart and its preparation method | |
| CN106578077A (en) | Milk tea containing kelp dietary fibers and preparation method thereof | |
| CN100444746C (en) | A refined health food of high and cold mountain area crop and processing technology thereof | |
| CN107468747A (en) | A kind of ginseng composition for being advantageous to anticancer, anti-cancer and preparation method thereof | |
| CN1742971A (en) | Instant preparation of Fructus sea semen Amomi and hawthorn and preparing process | |
| CN104857154A (en) | Traditional Chinese medicine composition for treating three-high diseases and preparation method therefor | |
| CN106387900A (en) | Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof | |
| CN104147345B (en) | A kind of Chinese medicine composition for treating cardiovascular autonomic neuropathy | |
| CN109395028A (en) | A kind of Ge Jingjia ginseng wine formula and preparation method preventing, treating three high diseases | |
| CN104106828A (en) | Solid beverage for reducing blood glucose | |
| CN105623995B (en) | Large-fruited Chinese hawthorn aperitif and beverage and preparation method thereof | |
| CN110638038A (en) | Medical formula nutritional meal replacement powder for controlling hyperglycemia and preparation method thereof | |
| CN103340919A (en) | Lucid ganoderma refined powder compound soft capsule and preparation method thereof | |
| CN107496648A (en) | A kind of function of male that strengthens improves the antifatigue diet therapy formula of fecundity relieving alcoholism and protecting liver | |
| CN100396189C (en) | Fruit food for nourishing liver and reducing fat and its producing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |